6[10]Thapar K, Scheithauer BW, Kovacs K, et al. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery, 1996, 38:765-771.
7[11]Hsu DW, Hakim F, Biller BM, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg, 1993, 78:753-761.
8[12]Beaulieu E, Kachra Z, Mousseau N, et al. Matrix metalloproteinases and their inhibitors in human pituitary tumors. Neurosurgery, 1999,46:1432-1441.
9[13]Kawamoto H, Uozumi T, Kawamoto K, et al. Type Ⅳ collagenase activity and cavernous sinus invasion in human pituitary adenomas.Acta Neurochir (Wien), 1996, 138:390-395.
10[14]Turner HE, Nagy Z, Gatter KC, et al. Angiogenesis in pituitary adenomas-relationship to endocrine function, treatment and outcome. J Endocrinol, 2000, 165:475-481.
